X

Trial Profile

Investigation of the effect of interleukin-1 receptor antagonist on markers of inflammation in non-ST elevation acute coronary syndromes.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 02 Aug 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Anakinra (Primary)
Indications Acute coronary syndromes
Focus Therapeutic Use
Acronyms MRC-ILA-HEART

Most Recent Events

30 Jan 2014 United Kingdom Clinical Research Network reports accrual to date is 97%
19 Nov 2013 Results presented at the 86th Annual Scientific Sessions of the American Heart Association.
31 May 2012 Additional trial locations added as reported by United Kingdom Clinical Research Network.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com